Navigation Links
AcroMetrix Announces Launch of First Liquid MRSA Positive Control
Date:3/25/2008

BENICIA, Calif., March 25 /PRNewswire/ -- AcroMetrix, a leading provider of quality control products and services for clinical diagnostic laboratories, announced today the launch of the first standardized External Quality Control for Methicillin Resistant Staphylococcus aureas (MRSA) molecular testing. The OptiQual MRSA Positive Control may be used to independently monitor all phases of MRSA DNA testing to ensure consistent and accurate results.

A study published October 2007 in the Journal of the American Medical Association estimated that MRSA infections resulted in the death of 18,650 out of 94,360 infected patients in the United States in 2005 -- death rate higher than that of HIV/AIDS in the same year. Since then, many efforts have been highlighted to urge state and federal lawmakers to enact a bill requiring all incoming hospital patients be screened for MRSA upon being admitted.

The costs involved when MRSA spreads through a hospital are staggering. The VA Medical Center of Pittsburgh estimated in September 2007 that nearly $35,000 is spent per patient in treatment for MRSA. In addition, the website for the Center for Medicare and Medicaid services states that CMS is analyzing the need to adjust reimbursements for hospital-acquired infections such as MRSA.

"With the urgency currently associated with the MRSA screening, it is critical that hospitals are able to implement screening tests with the appropriate level of quality control," said Michael J. Eck, President and CEO of AcroMetrix. "Many critical and costly treatment decisions will be based on the results of these tests so it is important for patients that the tests are properly monitored during all phases of the testing procedure."

Each lab can help to maintain CLIA compliance for qualitative PCR tests such as those used to detect MRSA DNA by using the OptiQual MRSA Positive Control daily. These controls contain inactivated whole MRSA bacteria, providing a safer method of monitoring the entire PCR process, from extraction through amplification and detection. Convenient and ready to use, the OptiQual MRSA Positive Control is stored at refrigerated temperatures. This product is for Research Use Only. Not for use in diagnostic procedures.

OptiQual(R) is a registered trademark of AcroMetrix.

About AcroMetrix

AcroMetrix, with facilities in Benicia, California and Alkmaar, The Netherlands, provides a comprehensive line of molecular and serological diagnostic quality control products that assist laboratories in meeting current government regulations regarding quality. AcroMetrix maintains this leadership role by consistently developing innovative standards, external run controls, and validation kits for molecular and serological testing in blood screening and clinical diagnostic laboratories. All AcroMetrix procedures are developed and manufactured under cGMP, following applicable FDA and ISO/EC standards. For more information on AcroMetrix please visit the company web site at http://www.acrometrix.com.


'/>"/>
SOURCE AcroMetrix
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AcroMetrix Announces Launch of PeliSpy Chagas Positive Control
2. Evalve Announces CE Mark Approval of the Worlds First Percutaneous Valve Repair System
3. Laerdal Medical Announces Strategic Relationship
4. Almost Family Announces Acquisition of Apex Home Health
5. Methodist Healthcare - Memphis Hospitals Announces the Extension of Tender Offers
6. MarketResearch.com Announces Distribution of Wireless Healthcare Research
7. MarketResearch.com Announces Distribution of CarbonFree Research
8. LCA-Vision Announces the Opening of its 75th LasikPlus(R) Vision Center in Tulsa, Oklahoma
9. MedCom Announces Card Activation Wins Significant Court Ruling
10. Tempo Participacoes S.A. Announces Increase of 16.8% in Net Revenue and of 46.3% in EBITDA for 2007
11. Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 2016 , ... It’s that time of year when most people have forgotten ... Athletic Association of Maryland (IAAM), Hall of Fame athlete and Garrison Forest School athletic ... , That’s why one of her first decisions when her IAAM two-year presidency began ...
(Date:2/9/2016)... , ... February 09, 2016 , ... ... and production of its newest mobility device, the StandUp Walker. Made entirely in ... design in the last 50 years. , StandUp Walker’s novel patent-pending design offers ...
(Date:2/9/2016)... New York, NY (PRWEB) , ... February 09, 2016 , ... ... announce the appointment of Dr. David Hung to the company´s Board of Directors. ... is a world class scientist and an exceptional entrepreneur.” said Juan Jose Chacon Quiros, ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... to expand access to affordable hearing aids , increase industry transparency, and ... in the United States. , “For the average consumer, the hearing aid industry ...
(Date:2/9/2016)... ... 09, 2016 , ... Sir Grout, the leading hard surface ... announce that many of their franchises have received the Super Service Award from ... franchises received customer recognition through positive reviews and testimonials, as well as evaluations ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... 9, 2016  Landauer, Inc. (NYSE: LDR ), ... and monitoring, outsourced medical physics services and high quality ... fiscal 2016 first quarter ended December 31, 2015. ... 2016 First Quarter Highlights , Revenue of $36.5 ... of 2015 , Domestic Radiation Measurement services revenues increased ...
(Date:2/9/2016)... , Feb. 9, 2016  Jazz Pharmaceuticals plc ... report its 2015 fourth quarter and full year financial ... of the financial markets.  Company management will host a ... p.m. EST/9:30 p.m. GMT to discuss fourth quarter and ... and financial update and guidance for 2016 financial results. ...
(Date:2/9/2016)... Amarantus BioScience Holdings, Inc. ... for Regenerative Medicine, Neurology and Orphan Diseases, today announced ... Source Capital Group,s 2016 Disruptive Growth & Healthcare Conference ... New York City . The Company,s presentation ... 12:30 pm by Gerald E. Commissiong , President ...
Breaking Medicine Technology: